Despite increasing incidence rates, researchers from New Haven, Conn.-based Yale University predict the prostate cancer death rate will decrease by 2050.
According to a study published Feb. 18 in Urologic Oncology, technological advances in prostate cancer screening, detection and treatment will contribute to a continued increase in incidence while lowering mortality.
“When we look at trends from the 1990s to now, there has actually been a steady decrease in prostate cancer mortality despite an increase in the incidence of prostate cancer,” Nicholas Brutus, MD, lead author of the study, said in a March 9 news release from Yale University. “We argue strongly that the main way mortality will decrease is through increased accessibility and screening.”
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
